Treatment of glaucoma and ocular hypertension with .beta..sub.3

Details Treatment of glaucoma and ocular hypertension with .beta..sub.3 Treatment of glaucoma and ocular hypertension with .beta..sub.3

1993-11-05

1996-11-26

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514376, 514450, 514451, A61K 31335, A61K 3142, A61K 3135

Patent

active

055786383

ABSTRACT:
This invention relates to a method of treating glaucoma or reducing intraocular pressure in a patient in need of such treatment which is based on the topical administration to the eye of a mammal or the systemic administration of a compound of the formula: ##STR1## wherein E', W', and the R groups are defined in the disclosure.

REFERENCES:
patent: 4309443 (1982-01-01), Smith et al.
patent: 4329358 (1982-05-01), Ainsworth et al.
patent: 4338333 (1982-07-01), Ainsworth et al.
patent: 4341793 (1982-07-01), Ferris
patent: 4382958 (1983-05-01), Duckworth
patent: 4385066 (1983-05-01), Ainsworth et al.
patent: 4391826 (1983-07-01), Mills et al.
patent: 4432993 (1984-02-01), Ferris
patent: 4568691 (1986-02-01), Marsham et al.
patent: 4585796 (1986-04-01), Alig et al.
patent: 4588749 (1986-05-01), Ferris
patent: 4593023 (1986-06-01), Hindley
patent: 4596800 (1986-06-01), Ainsworth et al.
patent: 4602044 (1986-07-01), Schmiegel et al.
patent: 4622342 (1986-11-01), Cantello et al.
patent: 4629737 (1986-12-01), Cantello
patent: 4652679 (1987-03-01), Alig et al.
patent: 4654371 (1987-03-01), Ainsworth et al.
patent: 4683312 (1987-07-01), Dominianni et al.
patent: 4692465 (1987-09-01), Hindley et al.
patent: 4695580 (1987-09-01), Ohashi et al.
patent: 4707497 (1987-11-01), Cecchi et al.
patent: 4772631 (1988-09-01), Holloway et al.
patent: 4783460 (1988-11-01), Cantello
patent: 4803293 (1989-02-01), Berge et al.
patent: 4871755 (1989-10-01), Alig et al.
patent: 4892886 (1990-01-01), Alig et al.
patent: 4927836 (1990-05-01), Holloway et al.
patent: 4977148 (1990-12-01), Holloway et al.
patent: 4992473 (1991-02-01), Anderson et al.
patent: 4999377 (1991-03-01), Caulkett et al.
patent: 5017619 (1991-05-01), Alig et al.
patent: 5045567 (1991-09-01), Kienzie
patent: 5061727 (1991-10-01), Bloom et al.
patent: 5153210 (1992-10-01), Ainsworth et al.
patent: 5166218 (1992-11-01), Alig et al.
patent: 5202466 (1993-04-01), Boigegrain et al.
patent: 5510376 (1996-04-01), Epstein et al.
Clark et al, Chemical Abstracts, vol. 104, No. 19, abstract #161536k, 1986, p. 15.
Investigative Opthalmology, pp. 455-457, Jun. 1974.
Pharmacological Basis of Therapeutics, Goodman & Gilman, Chapter 9, McMillan Publishing, NY 1980 (6th Ed.).
E.J. of Pharmacol., 100 (1984), 309-319.
Nature, vol. 309, pp. 163-165 (1984).
Current Eye Research, vol. 4, No. 7, pp. 775-780 (1985).
Brit. J. Pharmacol., 100:831-839 (1990).
Science, 245:1118-1121 (1989).

Affiliated with

Also associated with

Rating

Treatment of glaucoma and ocular hypertension with .beta..sub.3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of glaucoma and ocular hypertension with .beta..sub.3 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of glaucoma and ocular hypertension with .beta..sub.3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1973599